Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Jan. 31, 2022	Jan. 31, 2021
Operating activities:
Net income	$ 11,239	$ 7,852
Adjustments to reconcile net income to cash used for operating activities:
Depreciation and amortization	10,257	11,015
Stock-based compensation	552	523
Deferred income tax	854	1,925
Other, net	1,218	3,189
Changes in assets and liabilities:
Decrease in accounts receivable	8,340	7,103
Increase in inventory	(25,318)	(14,061)
Increase in other current assets	(3,534)	(873)
Decrease in accounts payable	(8,391)	(14,577)
Decrease in accrued liabilities	(18,248)	(2,692)
Increase (decrease) in income taxes payable	1,391	(2,790)
Decrease in deferred pension and postretirement benefits	(80)	(52)
Increase (decrease) in other long-term liabilities	404	(399)
Other, net	(335)	442
Cash used for operating activities	(21,651)	(3,395)
Investing activities:
Capital expenditures	(7,370)	(5,246)
Proceeds from disposition of capital assets	10	64
Cash used for investing activities	(7,360)	(5,182)
Financing activities:
Borrowings under credit facility	28,000	0
Repayments of credit facility borrowings	(3,000)	(5,000)
Repayments of other long-term debt	(228)	(541)
Common stock dividends paid	(2,587)	(2,637)
Issuance of common stock	55	10,030
Payroll tax paid to settle shares forfeited upon vesting of stock	(1,383)	(492)
Purchase of treasury stock	0	(1,927)
Cash provided by (used for) financing activities	20,857	(567)
Effect of exchange rate changes on cash and cash equivalents	(188)	949
Decrease in cash and cash equivalents	(8,342)	(8,195)
Cash and cash equivalents at beginning of period	40,061	51,621
Cash and cash equivalents at end of period	$ 31,719	$ 43,426